基本信息
浏览量:39
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Wani is an associate professor of organic and medicinal chemistry in the College of Science, University of Jeddah, Jeddah, Saudi Arabia. His core research area is the development of new small-molecule inhibitors and novel strategies and approaches to combat antimicrobial resistance (AMR). WHO has declared that antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. AMR has the potential to have an impact on humans at any stage of life, as well as the medical, veterinary, and agricultural sectors. This makes it one of the most important public health issues in the world. The cost of AMR to the economy is significant. In addition to death and disability, prolonged illness results in longer hospital stays, the need for more expensive medicines, and financial challenges for those impacted. Without effective antimicrobials, the success of modern medicine in treating infections, including during major surgery and cancer chemotherapy, would be at increased risk.
At the interface of chemistry and biology, Dr. Wani and his group are involved in the development of new small-molecule inhibitors, novel strategies, and approaches to circumvent the AMR problem. With extensive experience in the field of medicinal chemistry and drug discovery, he has authored/co-authored over 50 peer-reviewed research articles and 06 books and is the recipient of many prestigious honors, awards, and grants. He is a professional member of many scientific societies and is on the editorial board of many reputed scientific journals. Dr. Wani is working at the interface of chemistry and biology to advance the field with new questions and pertinent issues of the 21st century.
研究兴趣
论文共 90 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF MATERIALS CHEMISTRY Bno. 3 (2024): 552-576
International Journal of Biological Macromoleculesno. Pt 1 (2024): 132719-132719
RSC MEDICINAL CHEMISTRY (2024)
RSC Advancesno. 29 (2024): 21190-21202
Dalton transactions (Cambridge, England : 2003)no. 28 (2024): 11720-11735
RSC Medicinal Chemistry (2024)
RSC medicinal chemistryno. 6 (2024): 1942-1958
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn